Similar articles

• Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis.

  Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, Levine SR, Chaturvedi S, Kasner SE, Benesch CG, Sila CA, Jovin TG, Romano JG; Warfarin-Aspirin Symptomatic Intracranial Disease Trial Investigators. Chimowitz MI, et al. N Engl J Med. 2005 Mar 31;352(13):1305-16. doi: 10.1056/NEJMoa043033. N Engl J Med. 2005. PMID: 15800226 Clinical Trial.
• Design, progress and challenges of a double-blind trial of warfarin versus aspirin for symptomatic intracranial arterial stenosis.

  Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) Trial Investigators. Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) Trial Investigators. Neuroepidemiology. 2003 Mar-Apr;22(2):106-17. doi: 10.1159/000068744. Neuroepidemiology. 2003. PMID: 12656117 Clinical Trial. No abstract available.
• [Guidelines for antithrombotic therapy in atrial fibrillation: what the Italian Hemostasis and Thrombosis Society thinks].

  Prisco D. Prisco D. Haematologica. 2001 Sep;86(9 Suppl):12-3. Haematologica. 2001. PMID: 11759618 Italian. No abstract available.
• [Atrial fibrillation and thromboembolic events prevention. State of the art].

  Matteoli S, Trappolini M, Chillotti FM. Matteoli S, et al. Minerva Cardioangiol. 2001 Feb;49(1):1-13. Minerva Cardioangiol. 2001. PMID: 11279381 Review. Italian.
• Antithrombotic treatment in atrial fibrillation.

  Lip GY, Boos CJ. Lip GY, et al. Postgrad Med J. 2008 May;84(991):252-8. doi: 10.1136/hrt.2005.066944. Postgrad Med J. 2008. PMID: 18508982 Review.